Market Cap (In USD)
2.8 Million
Revenue (In USD)
-
Net Income (In USD)
-905.77 Thousand
Avg. Volume
28.54 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.013-0.12
- PE
- -
- EPS
- -
- Beta Value
- -0.618
- ISIN
- US67612C1027
- CUSIP
- 67612C102
- CIK
- 1626644
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ms. Christine M. Farrell
- Employee Count
- -
- Website
- https://www.odysseyhealthinc.com
- Ipo Date
- 2021-01-08
- Details
- Odyssey Health, Inc., a medical company, focuses on developing medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and PRV-001 and PRV-002 neurosteroid drug compounds to treat concussions and rare brain disorders. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was founded in 2014 and is based in Las Vegas, Nevada.
More Stocks
-
ADCOAdcore Inc.
ADCO
-
BATLIBOIBatliboi Limited
BATLIBOI
-
RBCP
-
TDO3D Oil Limited
TDO
-
ERIC-A
-
GRDI
-
GRBK-PAGreen Brick Partners, Inc.
GRBK-PA
-
NTM